Downregulation of miR-451 in cholangiocarcinoma help the diagnsosi and promotes tumor progression

Labib PL, Goodchild G, Pereira SP. Molecular Pathogenesis of Cholangiocarcinoma. BMC Cancer. 2019;19(1):185.

Article  PubMed  PubMed Central  Google Scholar 

Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168–79.

Article  PubMed  PubMed Central  Google Scholar 

Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15(2):95–111.

Article  CAS  PubMed  Google Scholar 

Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199–227.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–79.

Article  CAS  PubMed  Google Scholar 

Liu H, Ma L, Wang J. Overexpression of miR-25 is associated with progression and poor prognosis of cholangiocarcinoma. Exp Ther Med. 2019;18(4):2687–94.

CAS  PubMed  PubMed Central  Google Scholar 

Zhang M, Shi B, Zhang K. miR-186 Suppresses the Progression of Cholangiocarcinoma Cells Through Inhibition of Twist1. Oncol Res. 2019;27(9):1061–8.

Article  PubMed  PubMed Central  Google Scholar 

Collins AL, Wojcik S, Liu J, Frankel WL, Alder H, Yu L, et al. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Ann Surg Oncol. 2014;21(1):133–8.

Article  PubMed  Google Scholar 

Bai H, Wu S. miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer. OncoTargets Ther. 2019;12:11069–82.

Article  CAS  Google Scholar 

Khordadmehr M, Jigari-Asl F, Ezzati H, Shahbazi R, Sadreddini S, Safaei S, et al. A comprehensive review on miR-451: A promising cancer biomarker with therapeutic potential. Journal of cellular physiology. 2019;234(12):21716–31.

Article  CAS  PubMed  Google Scholar 

Duan Y, Zhang Y, Peng W, Jiang P, Deng Z, Wu C. MiR-7-5pand miR-451 as diagnostic biomarkers for papillary thyroid carcinoma in formalin-fixed paraffin-embedded tissues. Die Pharmazie. 2020;75(6):266–70.

CAS  PubMed  Google Scholar 

Liu G, Cao C, Zhu M. Peripheral Blood miR-451 May Serve as a Biomarker of Ischemic Stroke. Clin Lab. 2019;65(9):10.7754/Clin.Lab.2019.190309.

Ma YG, Han YZ, Zhang ZS, Yu Y, Xu XF, Yuan L. MiR-451 regulates proliferation and migration of colorectal cells by targeting MIF. Zhonghua Zhong Liu Za Zhi. 2020;42(4):312–8.

CAS  PubMed  Google Scholar 

Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene. 2011;30(23):2644–58.

Article  CAS  PubMed  Google Scholar 

Su Z, Zhao J, Rong Z, Geng W, Wang Z. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer. Int J Clin Exp Pathol. 2015;8(8):9154–60.

PubMed  PubMed Central  Google Scholar 

Li Y, Wang J, Dai X, Zhou Z, Liu J, Zhang Y, et al. miR-451 regulates FoxO3 nuclear accumulation through Ywhaz in human colorectal cancer. Am J Transl Res. 2015;7(12):2775–85.

CAS  PubMed  PubMed Central  Google Scholar 

Zeng T, Peng L, Chao C, Fu B, Wang G, Wang Y, et al. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT. Int J Clin Exp Pathol. 2014;7(11):7653–62.

PubMed  PubMed Central  Google Scholar 

Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, et al. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-beta. Carcinogenesis. 2013;34(11):2443–51.

Article  CAS  PubMed  Google Scholar 

Burkhart RA, Pawlik TM. Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Control. 2017;24(3):1073274817729235.

Article  PubMed  PubMed Central  Google Scholar 

Ling S, Ruiqin M, Guohong Z, Ying W. Expression and prognostic significance of microRNA-451 in human epithelial ovarian cancer. Eur J Gynaecol Oncol. 2015;36(4):463–8.

CAS  PubMed  Google Scholar 

Wang Z, Zhang H, Zhang P, Li J, Shan Z, Teng W. Upregulation of miR-2861 and miR-451 expression in papillary thyroid carcinoma with lymph node metastasis. Med Oncol. 2013;30(2):577.

Article  PubMed  Google Scholar 

Zhu C, Ren C, Han J, Ding Y, Du J, Dai N, et al. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Brit J Cancer. 2014;110(9):2291–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Leeneer K, Claes K. Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer. Adv Exp Med Biol. 2015;867:263–75.

Article  PubMed  Google Scholar 

Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, et al. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med. 2012;10:55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shivapurkar N, Weiner LM, Marshall JL, Madhavan S, Deslattes Mays A, Juhl H, et al. Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs. PLoS One. 2014;9(1).

Article  PubMed  PubMed Central  Google Scholar 

Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, et al. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol. 2011;17(35):3976–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nan Y, Han L, Zhang A, Wang G, Jia Z, Yang Y, et al. MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res. 2010;1359:14–21.

Article  CAS  PubMed  Google Scholar 

Godlewski J, Nowicki MO, Bronisz A, Nuovo G, Palatini J, De Lay M, et al. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell. 2010;37(5):620–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu SY, Deng SY, He YB, Ni GX. miR-451 inhibits cell growth, migration and angiogenesis in human osteosarcoma via down-regulating IL 6R. Biochem Biophys Res Commun. 2017;482(4):987–93.

Article  CAS  PubMed  Google Scholar 

Xu H, Mei Q, Shi L, Lu J, Zhao J, Fu Q. Tumor-suppressing effects of miR451 in human osteosarcoma. Cell Biochem Biophys. 2014;69(1):163–8.

Article  CAS  PubMed  Google Scholar 

Du M, Shi F, Zhang H, Xia S, Zhang M, Ma J, et al. Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of beta-catenin expression via EP3-4 receptor. Oncol Rep. 2015;34(2):715–26.

Article  CAS  PubMed  Google Scholar 

Loeffler MA, Hu J, Kirchner M, Wei X, Xiao Y, Albrecht T, et al. miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis. J Pathol. 2020;252(3):239–51.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif